Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C20H35NOS |
| Molecular Weight | 337.563 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCN[C@@H](C)[C@H](O)C1=CC=C(SC(C)C)C=C1
InChI
InChIKey=BFCDFTHTSVTWOG-PXNSSMCTSA-N
InChI=1S/C20H35NOS/c1-5-6-7-8-9-10-15-21-17(4)20(22)18-11-13-19(14-12-18)23-16(2)3/h11-14,16-17,20-22H,5-10,15H2,1-4H3/t17-,20-/m0/s1
Suloctidil is considered to be calcium antagonist. In addition to its vascular antispasmodic activity, suloctidil affects blood platelets and enhances brain energy metabolism. Suloctidil was being evaluated in many clinical trials for use in dementia and thrombotic disorders. Suloctidil induces hepatotoxicity.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0005262 |
0.45 µM [Ki] | ||
Target ID: GO:0070527 |
|||
Target ID: CHEMBL2760 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18027916 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2988158 |
Primary | Unknown Approved UseUnknown |
||
| Primary | Unknown Approved UseUnknown |
|||
| Curative | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis. | 2013-02 |
|
| Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of sphingolipid biosynthesis. | 2009-01-14 |
|
| Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. | 2008-01-24 |
|
| A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor. | 2004-02-15 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3036152
Suloctidil (10 microM) stimulated the release of prostacyclin (PGI2) from the rabbit aorta, the dog vena cava and the dog portal vein, in vitro.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QC04AX19
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
||
|
NCI_THESAURUS |
C29707
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
||
|
WHO-ATC |
C04AX19
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2536
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
CHEMBL588119
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
D013468
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
6604413
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
C152466
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
DB13340
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
XV1N1XY17K
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
100000082955
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
3452
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
m948
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB10752MIG
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
Suloctidil
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
DTXSID4045638
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
54767-75-8
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY | |||
|
259-332-1
Created by
admin on Wed Apr 02 08:59:15 GMT 2025 , Edited by admin on Wed Apr 02 08:59:15 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)